Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A coordinated transcriptional program controls de novo Golgi biogenesis.

The EMBO journal·2026
Same author

A delayed translocation into the endoplasmic reticulum controls the post-translational modifications of PD-L1.

Nature communications·2026
Same author

FKBP5 isoforms shape immune pathways related to tumor tolerance.

Cell death discovery·2026
Same author

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation.

Molecular oncology·2026
Same author

The interplay between autophagy and unconventional secretion in neurodegeneration.

Cell chemical biology·2026
Same author

Development and characterization of a membrane-permeant GRASP65-mimetic peptide that inhibits Golgi unlinking and cell cycle progression.

Methods (San Diego, Calif.)·2025

相关实验视频

Updated: Sep 12, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

541

作为选方法的一种光恢复策略,用于选择降调PD-L1表达的Sec61抑制剂.

Fulvia Vitale1, Gianluca Scerra1, Laura Marrone1

  • 1Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.

Nature communications
|August 6, 2025
PubMed
概括

研究人员开发了一种新的测试方法,用于选Sec61转位子抑制剂,这对于向癌症等疾病至关重要. 这种新方法可以识别阻断蛋白转位的小分子,有助于开发新疗法.

更多相关视频

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

相关实验视频

Last Updated: Sep 12, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

541
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

9.6K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • Sec61转位子抑制剂为治疗癌症和病毒感染提供了一个有希望的策略.
  • 目前缺乏用于识别Sec61抑制剂的敏感和直接选平台.

研究的目的:

  • 开发一种针对Sec61抑制剂的新,敏感和直接选试验.
  • 为了识别干扰蛋白质转移到内质网膜 (ER) 的小分子.

主要方法:

  • "在转位干扰时恢复发光" (RELITE) 试验的开发.
  • 利用火虫 luciferase 转移到 ER 中,然后通过 Sec61 抑制剂将其转移到细胞质中.
  • 通过干扰ER转位来抑制PD-L1蛋白表达的小分子的查.

主要成果:

  • 成功开发了RELITE试验,用于一次性选Sec61抑制剂.
  • 通过破坏ER转位,识别了阻碍PD-L1蛋白表达的小分子.
  • 证明了该试验能够选择促进向蛋白质降解的抑制剂的能力.

结论:

  • RELITE测试为选择Sec61抑制剂提供了一个强大的工具.
  • 这种方法有助于识别用于下调疾病相关蛋白质表达的化合物.
  • 开发的试验将加速发现各种病理的新疗法.